The global peritoneal dialysis market is driven by increase in the number of ESRD patient population. The market value of peritoneal dialysis market was $9.1 billion in 2012 and is expected to be $16.4 billion by 2020, at a CAGR of 7.60%.
The report “Global Peritoneal Dialysis Market Forecast, 2012-2020”, analyzes the market into two main segments such as peritoneal dialysis product and services. The segmentation of the market experienced a positive growth till 2012 with an increased awareness for sophisticated diagnostic techniques. Peritoneal dialysis product market accounted the largest share of 80% of the market.
APAC (India, China, Japan, and others) is the fastest growing market because of increased purchasing power of patients in India and China. Focus on the APAC region by the investors compelled by the matured western markets and the economic downturn in Europe are the major factors driving the APAC market.
The huge patient base in North America is making it possible to account the largest share in the dialysis market particularly in US and Canada. Moreover, the reimbursement scenarios are propelling the market in the region.
APAC accounts the second largest market share. Increase of prevalence pool of diabetes and hypertension, and improving reimbursement scenario and infrastructure is driving the market in the region. However, high cost of dialysis treatment and poor reimbursement are the key restraints to the growth of the dialysis market.
The report provides an extensive competitive landscaping of companies operating in this market. The key players of the market covered in this report are Baxter International, Inc. (U.S.) and Fresenius Medical Care AG & Co KGaA (Germany). The details of segment and country-specific company shares, news and deals, M&A, segment-specific pipeline products, product approvals, and product recalls of the major companies is also covered in the report
Customization Options
Along with the market data, you can also customize MMM assessments that meet your company’s specific needs. Customize to get comprehensive industry standard and deep-dive analysis of the following parameters:
Product Analysis
- Usage pattern (in-depth trend analysis) of products (segment-wise)
- Product matrix which gives a detailed comparison of product portfolio of each company mapped at country and sub-segment level
- End-user adoption rate analysis of the products (segment and country wise)
- Comprehensive coverage of product approvals, pipeline products, and product recalls
Key Data
- Products and services market scenario per region.
Surgeon’s/Physician’s Perception Analysis
- Fast turn-around analysis of surgeon’s response to market events and trends
- Pattern analysis of usage by physicians
- Surgeon’s/Physician’s opinion about products from different companies
Product/Brand Perception Matrix
- Comprehensive study of customers perception and behavior through our inbuilt social connect tool checking the virality and tonality of blogs
- Analysis of overall brand usage and familiarity and brand advocacy distribution
Pricing Trends
- Cost analysis of products in major countries
Competitive Intelligence
- The company share analysis of market for the top players of the market in the region
- The crucial developments and strategies of companies inculcating in their portfolio for the market
1 Introduction
1.1 Analyst Insights
1.2 Market Definitions
1.3 Market Segmentation & Aspects Covered
1.4 Research Methodology
2 Executive Summary
3 Market Overview
4 By Submarkets
4.1 Peritoneal Products
4.2 Peritoneal Dialysis Services
5 By Types
5.1 Continuous Cycling Peritoneal Dialysis (CCPD)
5.2 Continuous Ambulatory Peritoneal Dialysis (CAPD)
5.3 Intermittent PD (IPD)
5.4 PD Plus Therapy
6 By Geographies
6.1 North America
6.2 Europe
6.3 Rest of World
6.4 Asia-Pacific
Please fill in the form below to receive a free copy of the Summary of this Report
Please visit http://www.micromarketmonitor.com/custom-research-services.html to specify your custom Research Requirement
PRODUCT TITLE | PUBLISHED | |
---|---|---|
Peritoneal Products Peritoneal Products and Peritoneal Dialysis Services adds up to total |
Upcoming | |
Peritoneal Dialysis Services Peritoneal Dialysis Services and Peritoneal Products adds up to total |
Upcoming | |
Peritoneal Dialysis Concentrates/dialysates Peritoneal Dialysis Concentrates/dialysates and Peritoneal Dialysis Machines, |
Upcoming | |
Peritoneal Dialysis Machines Peritoneal Dialysis Machines and Peritoneal Dialysis Concentrates/dialysates, |
Upcoming | |
Peritoneal Dialysis Catheters Peritoneal Dialysis Catheters and Peritoneal Dialysis Concentrates/dialysates, |
Upcoming | |
Peritoneal Dialysis Transfer Sets Peritoneal Dialysis Transfer Sets and Peritoneal Dialysis Concentrates/dialysates, |
Upcoming | |
North American Peritoneal Dialysis The North American peritoneal dialysis market is driven by increase in the number of ESRD patient population. The report “North American Peritoneal Dialysis Market Forecast, 2012-2018”, analyzes the market into two main segments such as peritoneal dialysis product and services. The key players of the market covered in this report are Baxter International, Inc. (U.S.), Medical Components Inc. and Fresenius Medical Care AG & Co KGaA. |
Upcoming | |
Asia-Pacific Peritoneal Dialysis The Asia-Pacific peritoneal dialysis market is driven by increase in the number of ESRD patient population. The report “Asia-Pacific Peritoneal Dialysis Market Forecast, 2012-2018”, analyzes the market into two main segments such as peritoneal dialysis product and services. The key players of the market covered in this report are Baxter International, Inc., Fresenius Medical Care AG & Co KGaA (Germany), Gambro and Covidien. |
Upcoming | |
European Peritoneal Dialysis The European peritoneal dialysis market is driven by increase in the number of ESRD patient population. The report “European Peritoneal Dialysis Market Forecast, 2012-2018”, analyzes the market into two main segments such as peritoneal dialysis product and services. The key players of the market covered in this report are Baxter International, Inc. and Fresenius Medical Care AG & Co KGaA, Covidien and Gambro AG. |
Upcoming |